New injection aims to ease Post-Surgery pain without opioids

NCT ID NCT07533786

Recruiting now Symptom relief Sponsor: Haisco Pharmaceutical Group Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called HSK55718 for pain after abdominal surgery. About 200 adults will receive either the new drug, morphine, or a placebo. Researchers will measure pain relief and satisfaction. The goal is to see if HSK55718 is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HSK55718 injection
What this could lead to: If successful, this could provide a new option for managing pain after abdominal surgery with potentially fewer side effects than morphine.
What could go wrong: This is an early Phase 2 trial with only 200 people, so results may not apply to everyone. The drug may not work better than existing treatments or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN AFTER SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAIN AFTER SURGERY

Contacts and locations

Locations

Sichuan Provincial People's Hospital
RECRUITING

Chengdu, Sichuan, China
The Third Xiangya Hospital of Central South University
RECRUITING

Changsha, Hunan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.